Tech Company Financing Transactions
Opal Therapeutics Funding Round
On 8/6/2026, Opal Therapeutics raised $1.3 million in financing from National Science Foundation.
Transaction Overview
Company Name
Announced On
8/6/2026
Transaction Type
Debt
Amount
$1,250,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
135 Mississippi Street
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Opal Therapeutics is a women's health biotech company developing lab-grown uterine models, including endometrial & myometrial organoids. Aiming to transform how we study and treat conditions like fibroids, endometriosis, & other gynecological disorders. We use patient-derived uterine organoids that mimic the structure and biology of real human tissue. Our models provide a more accurate, scalable, and clinically relevant platform for developing and testing treatments in women's health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Morgan Stanton
Browse more venture capital transactions:
Prev: 8/6/2026: Enrola venture capital transaction
Next: 8/6/2026: Tenica Global Solutions venture capital transaction
Share this article
About Database of VC Transactions
We document funding rounds that are announced publicly. VC investment data records on this site come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs